Safety and Efficacy Study of Autologous BM-MNC Processed by Two Methods for Treating Patients With Chronic Limb Ischemia

Xuanwu Hospital, Beijing50 enrolled

Overview

Using autologous bone marrow mononuclear cells (BM-MNC) to treat patients with chronic limb ischemia has been proved safe and effective. However, processing bone marrow by Ficoll density gradient centrifugation is not only time consuming but also expensive. Manually processing of bone marrow also results in large variation in therapeutic cell quantity and quality which directly lead deviation of safety and efficacy of the cell therapy. This study is aiming to compare an automated bone marrow processing system with a conventional manual method in term of safety and efficacy. ResQ system developed by Thermogenesis in USA provides an automatic cell processing system for bone marrow. The system takes less than 30 minutes to concentrate the therapeutic mononuclear cells including stem cells in a closed system without adding any additive such as separation reagent (Ficoll). The system also be able to be operated at point of care. The study is designed to prove no inferior of safety and efficacy of bone marrow cells processed by ResQ to those of cells using conventional manual method. The conventional manual method is involved Ficoll density gradient centrifugation and cell washing stems in an open system. Each of test arms (ResQ vs manual method) consists of 25 patients. The primary outcome is safety which is measured by cell treatment-related adverse events. The secondary endpoints include resting ankle-brachial pressure index (ABI)and toe brachial pressure index (TBI) , transcutaneous oxygen pressure (TcPO2), claudication distance, rest pain scale evaluation, collateral vessel scale, etc.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Eligibility

Sex: ALLMin age: 20 YearsMax age: 80 Years

Medical Language ↔ Plain English

Inclusion Criteria: 1. fontaine's stage 2-4 or resting ABI \<0.7 2. age between 20 and 80 years old 3. sign informed consent, voluntary subjects 4. diagnosis of lower extremity arterial occlusive disease, or diabetic lower limb ischemia, or Buerger's disease Exclusion Criteria: 1. poorly controlled diabetes (HBA1c\> 7.0%) and proliferative retinopathy (III-IV stage) 2. malignancy history in the past five years or serum level of tumor markers elevated more than doubled 3. severe heart, liver, kidney, respiratory failure or poor general condition can not tolerate BM-MNC transplantation 4. serious infections (such as cellulitis, osteomyelitis, etc.)or gangrene that a major amputation cannot be avoided 5. aortic or iliac or common femoral artery occlusion 6. pregnant female, or reproductive age female who wants to give birth throughout the course of the study 7. life expectancy less than a year

Outcomes

Primary Outcomes

Cell treatment-related adverse event

1. Temperature,Pulse,Respiration,Blood Pressure 2. Routine analysis of blood and urine, 3. Liver function(ALT：alanine aminotransferase,AST：aspartate transferase), Renal function(Blood urea nitrogen,Creatinine;) Function of coagulation(APTT,PT,Fib,TT） 4. ECG（Electrocardiography） 5. local inflammatory response 6. Cell-treatment related death 7. Cell-treatment related unexpected amputation.

Time frame: 2-wk after bone marrow transplantation

Secondary Outcomes

ulcer size

Measuring ulcer area (cm2) and depth (mm)of limb : For each ulcer , photographically record the area and depth with a ruler in order to calculate the ulcer area in square millimeters.

Time frame: Post bone marrow transplantation: 1, 3, 6, 12 months

rest pain score.

Scoring the rest pain based on the degree of pain as following five scales): 0 level-0 point: no pain; 1. level-1 point: occasional pain which can be recalled; 2. level-2 points: the pain often but can be tolerated, without or with a little analgesics; 3. level-3 points: often with need of general analgesics; 4. level -4 points: affect sleeping due to the pain, general pain medication being difficult to alleviate. Before transplantation: points; after transplantation: points.

Time frame: Post bone marrow transplantation: 1，3, 6, 12 months

cold sensation score

based on a sense of cold as following five scales: 0 level-0 point: no cold sensation; 1. level-1 point, or : Accasionally cold feeling; 2. level-2 points: Often with cold feeling; 3. level-3 points: significantly cold feeling. and can be significantly improved when using a local insulation. 4. level-4 points: significantly cold feeling，and can not be significantly improved when using a local insulation.

Time frame: Post bone marrow transplantation:,1，3, 6, 12 months

claudication distance (m)

Measurement of claudication distance (m)： For patients with intermittent claudication, treadmill exercise test (no tilt, speed 3km/hr) is employed to measure claudication distance.

Time frame: Post bone marrow transplantation:1, 3, 6, 12 months

Resting ABI

Measurement of ABI(ankle brachial index, ABI): Measure arterial pressure with a laser Doppler, and then calculate the ankle-brachial index, that is a ratio of ankle arterial blood pressure to brachial arterial blood pressure at rest.

Time frame: Post bone marrow transplantation: 1,3, 6, 12 months

Resting TcPO2 (mmHg)

Transcutaneous oxygen pressure(TcPO2) should be measured at the same site in the ischemic limb at rest.

Time frame: Post bone marrow transplantation:1, 3, 6, 12 months

Collateral vessel score

Collateral vessel score: Using DSA(Digital subtraction angiography)or CTA(computed tomographic angiography) to score the collateral vessel formation. A mean score is obtained for each ischemic limb by 3 independent interventionists based on the following 4 level score: 0 (no new collateral vessels) * 1 (A little new collateral vessels) * 2 (moderate new collateral blood vessels) * 3 (Rich new collateral vessels)

Time frame: Post bone marrow transplantation: 1,3, 6, 12 months

Amputation rate

Amputation rate and level is recorded.

Time frame: Post bone marrow transplantation:1, 3, 6, 12 months

Skin microcirculation measurement

using PeriMed "laser-Doppler flowmetry" measure the skin microcirculation on the same site in the ischemic limb at rest.

Time frame: 1,3,6,12 months post transplantation

Resting TBI

Measurement of TBI（Toe Brachial Index): Measure arterial pressure with a laser Doppler, and then calculate Toe Brachial Index, that is a ratio of toe arterial blood pressure to brachial arterial blood pressure.

Time frame: Post bone marrow transplantation: 1,3, 6, 12 months

Safety and Efficacy Study of Autologous BM-MNC Processed by Two Methods for Treating Patients With Chronic Limb Ischemia

Overview

Conditions

Interventions

Eligibility

Locations (1)

Outcomes

Primary Outcomes

Secondary Outcomes

Central Contacts